Aktywność biologiczna modyfikowanych nukleozydów. Część 3

Journal Title: Wiadomości Chemiczne - Year 2018, Vol 72, Issue 9

Abstract

Part III of the review devoted to biological activities of nucleoside derivatives presents a further description of analogues modified in the sugar residue with particular focus on those with altered configuration in the 2’ or 3’ position, e.g. cytarabine – an old anticancer chemotherapy agent used to treat acute myeloid leukemia, acute lymphoblastic leukemia, and non-Hodgkin’s lymphomas; fludarabine – derivative of vidarabine used as a drug in the treatment of chronic lymphocytic leukemia, and non-Hodgkin lymphomas; clofarabine – approved by the FDA in 2004, a new-generation second-line drug for recurrent acute myeloid leukemia; and fialuridine – examined as a potential therapeutic for the treatment of HBV infection, however, clinical trials ended tragically. In the last section of the review derivatives with other modifications in the sugar moiety are described – carbocyclic and acyclic analogues, l-nucleosides and 5’-modified nucleosides. Among others, very important modified nucleosides are listed e.g. acyclovir, ganciclovir, DHPA, tenofovir, cyclopentenylcytosine, entecavir, carbovir, abacavir, lamivudine, telbivudine and sinefungin VA. All parts together make a possibly complete and concise review, including the latest reports, the most important groups of modified nucleosides, and should be considered as a whole. In the context of the activities description, there are references to the important molecular targets, mechanisms of action, pharmacodynamics, pharmacokinetics, toxicity, resistance, in vitro and in vivo tests or prodrug strategies, which can be a starting point for further study for chemists interested in medicinal chemistry.

Authors and Affiliations

Maurycy Szlenkier

Keywords

Related Articles

Kompleksy jonów metali d- i f-elektronowych z N-tlenkiem pirydyny i związkami pochodnymi : badania spektroskopowe

This article reviews results of studies, collected in the literature, related to complexation abilities of pyridine N-oxides, including forms and properties of dand f-metal ion complexes with this group of ligands. In th...

Nowiczok(I) i substancje A

When we hear the slogan ‘chemical weapons’, we are usually reminded of a photograph of marching geese, like the blind Ententa soldiers who were darkened after the Ypres chemical attack in Breugel’s painting. After the en...

Badanie struktury i dynamiki N-terminalnych sekwencji dermorfiny i ich analogów z wykorzystaniem spektroskopii NMR w ciele stałym i rentgenografii

Deltorphin I (Tyr-d-Ala-Phe-Asp-Val-Val-Gly-NH_2) and dermorphin (Tyr-d-Ala-Phe- -Gly-Tyr-Pro-Ser-NH_2) are natural opioid peptides that have been isolated from the skin of South American frogs [1]. The presence of d-ami...

1’-homonukleoz(t)ydy : synteza i aktywność biologiczna

Long-lasting interest in the synthesis of nucleos(t)ide analogues is dictated by hope to obtain compounds possessing antibacterial, antiviral and antitumor activities [1, 2]. Introduction of a methylene linker between an...

Syntetyczne odpowiedniki fosfoenolopirogronianu, czyli jak naśladować biosyntezę kwasów ulozonowych

Ulosonic acids are key intermediated in many important biochemical pathways. One of them is DAH, which takes part in the shikimic acid pathway, as precursor in aromatic amino acids biosynthesis [1]. Another interesting c...

Download PDF file
  • EP ID EP568411
  • DOI -
  • Views 152
  • Downloads 0

How To Cite

Maurycy Szlenkier (2018). Aktywność biologiczna modyfikowanych nukleozydów. Część 3. Wiadomości Chemiczne, 72(9), -. https://www.europub.co.uk/articles/-A-568411